Application 206266
- Type
- ANDA
- Sponsor
- PRINSTON PHARMA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FEBUXOSTAT | FEBUXOSTAT | TABLET;ORAL | 40MG | No | No |
| 002 | FEBUXOSTAT | FEBUXOSTAT | TABLET;ORAL | 80MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 43547-295 | FEBUXOSTAT | febuxostat | Solco Healthcare US LLC | ANDA | Current |
| 43547-295 | FEBUXOSTAT | febuxostat | Solco Healthcare US LLC | ANDA | Current |
| 43547-295 | FEBUXOSTAT | febuxostat | Solco Healthcare US LLC | ANDA | Current |
| 43547-296 | FEBUXOSTAT | febuxostat | Solco Healthcare US LLC | ANDA | Current |
| 43547-296 | FEBUXOSTAT | febuxostat | Solco Healthcare US LLC | ANDA | Current |